Association of vitamin D receptor gene TaqI, FokI and ApaI variants with arteriovenous fistula failure in hemodialysis patients

J Vasc Access. 2018 May;19(3):303-310. doi: 10.1177/1129729817752860. Epub 2018 Mar 15.

Abstract

Purpose: We investigated the influence of the vitamin D receptor gene TaqI (rs731236), ApaI (rs7975232), and FokI (rs2228570) polymorphisms in arteriovenous fistula failure in hemodialysis patients.

Methods: This study was carried out with 54 patients who experienced two or more fistula failures in the late period after arteriovenous fistula operation and 58 control patients with no history of arteriovenous fistula failure in 3 years or longer. The polymerase chain reaction-restriction fragment length polymorphism method was used to determine the vitamin D receptor TaqI, FokI, and ApaI polymorphisms.

Results: For vitamin D receptor gene TaqI and Fok1 polymorphisms, no significant association was found between the two groups ( p > 0.05). However, a statistically significant association was determined for ApaI polymorphism between the two groups ( p = 0.02). In patients, ApaI AA, AC, and CC genotype frequencies were found as 21 (38.9%), 32 (59.3%), and 1 (1.8%), respectively. However, genotype frequencies of AA, AC, and CC in the control group were 29 (50%), 22 (37.9%), and 7 (12.1%), respectively. In all three polymorphisms, no significant difference was found between the two groups in terms of allele frequencies ( p > 0.05).

Conclusion: Vitamin D receptor ApaI AC genotype may be a possible cardiovascular risk factor for the development of arteriovenous fistula failure.

Keywords: Vitamin D; arteriovenous fistula failure; hemodialysis; single nucleotide polymorphism; vitamin D receptor.

MeSH terms

  • Aged
  • Arteriovenous Shunt, Surgical / adverse effects*
  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Receptors, Calcitriol / genetics*
  • Renal Dialysis*
  • Risk Factors
  • Treatment Failure

Substances

  • Receptors, Calcitriol
  • VDR protein, human